EMERGENT CAPITAL, INC. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q3 FY2020 As of Aug 31, 2020	Q2 FY2020 As of May 31, 2020	Q1 FY2020 As of Feb 29, 2020	Q4 FY2019 As of Nov 30, 2019	Q3 FY2019 As of Aug 31, 2019	Q2 FY2019 As of May 31, 2019	Q1 FY2019 As of Feb 28, 2019	Q3 FY2018 As of Sep 30, 2018	Q2 FY2018 As of Jun 30, 2018	Q1 FY2018 As of Mar 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q3 FY2017 As of Sep 30, 2017	Q2 FY2017 As of Jun 30, 2017	Q1 FY2017 As of Mar 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q3 FY2016 As of Sep 30, 2016	Q2 FY2016 As of Jun 30, 2016	Q1 FY2016 As of Mar 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q3 FY2015 As of Sep 30, 2015
ASSETS
Cash and cash equivalents
Primary Beneficiary
Total cash and cash equivalents
Certificate of deposit
Certificates of deposit
Prepaid expenses and other assets
Primary Beneficiary
Total prepaid expenses and other assets
Operating lease asset (Note 18)
Deposits - other
Primary Beneficiary
Total deposits - other

Deposits on purchases of life settlements
Structured settlement receivables, at estimated fair value
Structured settlement receivables at cost, net
Life settlements, at estimated fair value
Primary Beneficiary
Total life settlements, at estimated fair value
Receivable for maturity of life settlements
Primary Beneficiary
Total receivable for maturity of life settlements
Fixed assets, net
Deferred debt costs, net
Investment in limited partnership, at estimated fair value (Note 11)
Investment in deconsolidated subsidiaries, at estimated fair value (Note 3)
Investment in affiliates
Primary Beneficiary
Total investment in affiliates
Deferred tax asset
Total assets

LIABILITIES AND STOCKHOLDERS’ EQUITY
Liabilities
Accounts payable and accrued expenses
Primary Beneficiary
Total accounts payable and accrued expenses
Other liabilities
Primary Beneficiary
Total other liabilities
Promissory Notes (Note 13)
Operating lease liability (Note 18)
Interest payable
15.00% Promissory Note
8.50% Senior Unsecured Convertible Notes
Senior Secured Notes
Five Point Zero Percent Senior Unsecured Convertible Notes Due 2023
15.0% Senior Secured Notes
Convertible Notes
8.5% Senior Secured Notes

5.0% Convertible Notes, net of discount and deferred debt costs (Note 14)
8.50% Senior Unsecured Convertible Notes
Five Point Zero Percent Senior Unsecured Convertible Notes Due 2023
Convertible Notes
Total 5.0% Convertible Notes, net of discount and deferred debt costs (Note 14)

8.5% Senior Secured Notes, net of deferred debt costs (Note 15)
Senior Secured Notes
15.0% Senior Secured Notes
8.5% Senior Secured Notes
Total 8.5% Senior Secured Notes, net of deferred debt costs (Note 15)

White Eagle Revolving Credit Facility, at estimated fair value (VIE Note 4 & Note 9)
Deferred tax liability
Current tax liability
Total liabilities

Stockholders’ Equity
Common stock (par value $0.01 per share, 80,000,000 authorized at March 31, 2017 and December 31, 2016; 29,021,844 issued and 28,413,844 outstanding as of March 31, 2017 and December 31, 2016
Common stock (par value $0.01 per share, 415,000,000 authorized at August 31 ,2020 and November 30, 2019; 159,263,140 issued and 158,655,140 outstanding as of August 31, 2020; 158,365,275 issued and 157,757,275 outstanding as of November 30, 2019)
Preferred stock (par value $0.01 per share, 40,000,000 authorized; 0 issued and outstanding as of August 31, 2020 and November 30, 2019)
Treasury Stock, net of issuance cost 608,000 shares as of August 31, 2020 and November 30, 2019)
Additional paid-in-capital
Accumulated deficit
Total stockholders’ equity

Total liabilities and stockholders’ equity

Comments